File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Enucleation of painful blind eye for refractory intraocular lymphoma after dose-limiting chemotherapy and radiotherapy

TitleEnucleation of painful blind eye for refractory intraocular lymphoma after dose-limiting chemotherapy and radiotherapy
Authors
Chow, PPcHo, SLLai, WWAu, WY
KeywordsMedicine & Public Health
Hematology
Oncology
Issue Date2012
PublisherSpringer Verlag. The Journal's web site is located at http://link.springer.de/link/service/journals/00277/index.htm
Citation
Annals Of Hematology, 2012, v. n. 10, p. 1657-1658 How to Cite?
DOI: http://dx.doi.org/10.1007/s00277-012-1452-z
Persistent Identifierhttp://hdl.handle.net/10722/147094
ISSN
0939-5555
2023 Impact Factor: 3.0
2023 SCImago Journal Rankings: 0.912
ISI Accession Number ID
WOS:000308356900018
References

Taoka K, Yamamoto G, Kaburaki T, Takahashi T, Araie M, Kurokawa M (2011) Treatment of primary intraocular lymphoma with rituximab, high dose methotrexate, procarbazine, and vincristine chemotherapy, reduced whole-brain radiotherapy, and local ocular therapy. Br J Haematol. doi:10.1111/j.1365-2141.2011.08938.x

Hon C, Kwok AK, Shek TW, Au WY (2003) Unusual locations of involvement by malignancies: case 4. Bilateral hypopyon heralding CNS relapse of cutaneous natural killer cell lymphoma. J Clin Oncol 21(17):3373–3374 doi: 10.1200/JCO.2003.01.048

Rajagopal R, Harbour JW (2011) Diagnostic testing and treatment choices in primary vitreoretinal lymphoma. Retina 31(3):435–440 doi: 10.1097/IAE.0b013e31820a6743

Grimm SA, McCannel CA, Omuro AM, Ferreri AJ, Blay JY, Neuwelt EA et al (2008) Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report. Neurology 71(17):1355–1360 doi: 10.1212/01.wnl.0000327672.04729.8c

Hon C, Au WY, Shek TW (2005) Intraocular lymphoma as a masquerade syndrome complicating cerebral lymphoma of the corpus callosum. Ann Hematol 84(3):203–204 doi: 10.1007/s00277-004-0975-3

Pe’er J, Hochberg FH, Foster CS (2009) Clinical review: treatment of vitreoretinal lymphoma. Ocul Immunol Inflamm 17(5):299–306 doi: 10.3109/09273940903370755

Mineo JF, Scheffer A, Karkoutly C, Nouvel L, Kerdraon O, Trauet J et al (2008) Using human CD20-transfected murine lymphomatous B cells to evaluate the efficacy of intravitreal and intracerebral rituximab injections in mice. Invest Ophthalmol Vis Sci 49(11):4738–4745 doi: 10.1167/iovs.07-1494

 

DC FieldValueLanguage
dc.contributor.authorChow, PPcen_HK
dc.contributor.authorHo, SLen_HK
dc.contributor.authorLai, WWen_HK
dc.contributor.authorAu, WYen_HK
dc.date.accessioned2012-05-25T07:50:38Z-
dc.date.available2012-05-25T07:50:38Z-
dc.date.issued2012en_HK
dc.identifier.citationAnnals Of Hematology, 2012, v. n. 10, p. 1657-1658en_HK
dc.identifier.issn0939-5555en_HK
dc.identifier.urihttp://hdl.handle.net/10722/147094-
dc.languageengen_US
dc.publisherSpringer Verlag. The Journal's web site is located at http://link.springer.de/link/service/journals/00277/index.htmen_HK
dc.relation.ispartofAnnals of Hematologyen_HK
dc.rightsThe Author(s)en_US
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.en_US
dc.subjectMedicine & Public Healthen_US
dc.subjectHematologyen_US
dc.subjectOncologyen_US
dc.titleEnucleation of painful blind eye for refractory intraocular lymphoma after dose-limiting chemotherapy and radiotherapyen_HK
dc.typeArticleen_HK
dc.identifier.openurlhttp://www.springerlink.com/link-out/?id=2104&code=V077646K35416725&MUD=MPen_US
dc.identifier.emailLai, WW: wicolai@hku.hken_HK
dc.identifier.authorityLai, WW=rp00531en_HK
dc.description.naturepublished_or_final_versionen_US
dc.identifier.doi10.1007/s00277-012-1452-zen_HK
dc.identifier.pmid22450776-
dc.identifier.scopuseid_2-s2.0-84867337100en_HK
dc.relation.referencesTaoka K, Yamamoto G, Kaburaki T, Takahashi T, Araie M, Kurokawa M (2011) Treatment of primary intraocular lymphoma with rituximab, high dose methotrexate, procarbazine, and vincristine chemotherapy, reduced whole-brain radiotherapy, and local ocular therapy. Br J Haematol. doi:10.1111/j.1365-2141.2011.08938.xen_US
dc.relation.referencesdoi: 10.1111/j.1365-2141.2011.08938.xen_US
dc.relation.referencesHon C, Kwok AK, Shek TW, Au WY (2003) Unusual locations of involvement by malignancies: case 4. Bilateral hypopyon heralding CNS relapse of cutaneous natural killer cell lymphoma. J Clin Oncol 21(17):3373–3374en_US
dc.relation.referencesdoi: 10.1200/JCO.2003.01.048en_US
dc.relation.referencesRajagopal R, Harbour JW (2011) Diagnostic testing and treatment choices in primary vitreoretinal lymphoma. Retina 31(3):435–440en_US
dc.relation.referencesdoi: 10.1097/IAE.0b013e31820a6743en_US
dc.relation.referencesGrimm SA, McCannel CA, Omuro AM, Ferreri AJ, Blay JY, Neuwelt EA et al (2008) Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report. Neurology 71(17):1355–1360en_US
dc.relation.referencesdoi: 10.1212/01.wnl.0000327672.04729.8cen_US
dc.relation.referencesHon C, Au WY, Shek TW (2005) Intraocular lymphoma as a masquerade syndrome complicating cerebral lymphoma of the corpus callosum. Ann Hematol 84(3):203–204en_US
dc.relation.referencesdoi: 10.1007/s00277-004-0975-3en_US
dc.relation.referencesPe’er J, Hochberg FH, Foster CS (2009) Clinical review: treatment of vitreoretinal lymphoma. Ocul Immunol Inflamm 17(5):299–306en_US
dc.relation.referencesdoi: 10.3109/09273940903370755en_US
dc.relation.referencesMineo JF, Scheffer A, Karkoutly C, Nouvel L, Kerdraon O, Trauet J et al (2008) Using human CD20-transfected murine lymphomatous B cells to evaluate the efficacy of intravitreal and intracerebral rituximab injections in mice. Invest Ophthalmol Vis Sci 49(11):4738–4745en_US
dc.relation.referencesdoi: 10.1167/iovs.07-1494en_US
dc.identifier.spage1657en_HK
dc.identifier.epage1658en_HK
dc.identifier.eissn1432-0584en_US
dc.identifier.isiWOS:000308356900018-
dc.publisher.placeGermanyen_HK
dc.description.otherSpringer Open Choice, 25 May 2012en_US
dc.identifier.scopusauthoridChow, PPc=55122828500en_HK
dc.identifier.scopusauthoridHo, SL=37124072900en_HK
dc.identifier.scopusauthoridLai, WW=7402231098en_HK
dc.identifier.scopusauthoridAu, WY=7202383089en_HK
dc.identifier.citeulike10513987-
dc.identifier.issnl0939-5555-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats